1. Home
  2. ABCL vs CAR Comparison

ABCL vs CAR Comparison

Compare ABCL & CAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$12.19

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Logo Avis Budget Group Inc.

CAR

Avis Budget Group Inc.

N/A

Current Price

$107.85

Market Cap

3.9B

ML Signal

N/A

Company Overview

Basic Information
Metric
ABCL
CAR
Founded
2012
1946
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Rental/Leasing Companies
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.9B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
ABCL
CAR
Price
$12.19
$107.85
Analyst Decision
Strong Buy
Hold
Analyst Count
12
8
Target Price
$16.82
★ $122.86
AVG Volume (30 Days)
★ 4.3M
359.4K
Earning Date
11-09-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
★ 50.71
EPS
★ N/A
N/A
Revenue
$75,128,000.00
★ $11,652,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.12
$1.53
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 160.56
N/A
52 Week Low
$2.75
$85.96
52 Week High
$14.98
$847.70

Technical Indicators

Market Signals
Indicator
ABCL
CAR
Relative Strength Index (RSI) 48.43 49.38
Support Level $11.78 $102.20
Resistance Level $12.88 $113.37
Average True Range (ATR) 0.83 4.82
MACD 0.01 1.35
Stochastic Oscillator 40.11 70.06

Price Performance

Historical Comparison
ABCL
CAR

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About CAR Avis Budget Group Inc.

Avis Budget Group Inc is a provider of mobility solutions through its three brands Avis, Budget and Zipcar, as well as several other brands, well recognized in their respective markets. Its brands offer a range of options, from car and truck rental to car sharing. The company operates in two reportable business segments: Americas - (i) vehicle rental operations in North America, South America, Central America and the Caribbean, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly. International - consisting of (i) vehicle rental operations in Europe, the Middle East, Africa, Asia and Australasia, (ii) car sharing operations in certain of these markets, and (iii) licensees in the areas in which do not operate directly.

Share on Social Networks: